Back
Future FinTech Group 10K Form
Sell
22
FTFT
Future FinTech Group
Last Price:
$0.17
Seasonality Move:
123.25%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
2020-11-16 | 10Q | FTFT/Future FinTech Group Quarterly |
2020-11-04 | 10K | FTFT/Future FinTech Group Annual |
2020-08-14 | 10Q | FTFT/Future FinTech Group Quarterly |
2020-07-06 | 10Q | FTFT/Future FinTech Group Quarterly |
2020-06-02 | 10K | FTFT/Future FinTech Group Annual |
2019-11-14 | 10Q | FTFT/Future FinTech Group Quarterly |
Receive FTFT News And Ratings
See the #1 stock for the next 7 days that we like better than FTFT
FTFT Financial Statistics
Sales & Book Value
Annual Sales: | $34.9M |
---|---|
Cash Flow: | $-1.6M |
Price / Cash Flow: | 0 |
Annual Sales: | $1.80 |
Price / Book: | 0.09 |
Profitability
EPS (TTM): | -2.37000 |
---|---|
Net Income (TTM): | $-37.6M |
Gross Margin: | $4.9M |
Return on Equity: | -86.15% |
Return on Assets: | -61.97% |
Future FinTech Group Earnings Forecast
Key Future FinTech Group Financial Ratios
-
The Gross Profit Margin over the past 22 years for FTFT is 14.02%.
-
The Selling, General & Administrative Expenses for FTFT have been equal to 44.52% of Gross Profit Margin.
-
The Research & Development expenses have been 0.98% of Revenue.
-
The Net Earning history of FTFT is -96.52% of Total Revenues.
-
Per Share Earnings over the last 23 years have been positive in 10 years.
Future FinTech Group Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | NASDAQ |
---|---|
Industry: | Financial Services |
Sector: | Financials |
Current Symbol: | FTFT |
CUSIP: | 36117V |
Website: | ftft.com |
Debt
Debt-to-Equity Ratio: | 0.03 |
---|---|
Current Ratio: | 2.68 |
Quick Ratio: | 1.54 |
Price-to-Earnings
Trailing P/E Ratio: | 0 |
---|---|
Forward P/E Ratio: | 0 |
FTFT Technical Analysis vs Fundamental Analysis
Sell
22
Future FinTech Group (FTFT)
is a Sell
Is Future FinTech Group a Buy or a Sell?
-
Future FinTech Group stock is rated a SellThe current Future FinTech Group [FTFT] share price is $0.17. The Score for FTFT is 22, which is 56% below its historic median score of 50, and infers higher risk than normal.